JOIN NOW

Become a Member of CEDAS today!

Backstage in Bioscience: An Event for Economic Developers

5/22/2019
8:15 AM – 11:00 AM

Cell and Genome Sciences Building
400 Farmington Avenue
Farmington, CT06030
Driving Directions

 

Join us for this unique event highlighting Connecticut’s growing future in bioscience!  Attendees will learn about the current state of the bioscience industry in Connecticut and the wide range of statewide resources available for bioscience enterprises.  The event features a moderated panel for bioscience entrepreneurs and leaders to share challenges, successes and actionable ideas for economic developers and community leaders.

Network with industry leaders during the sponsored breakfast and join us for free tours of the TIP facility to follow the program.

Program Agenda

8:15 to 9:00 a.m.                 
Registration & networking breakfast

9:00 to 11:00 a.m.               
Developing an Environment that Welcomes Bioscience 

  • Welcome, Garrett Sheehan, President, Connecticut Economic Development Association
  • Paul Pescatello, We Work for Health
  • Overview of the Bioscience Industry in CT, Dawn Hocevar, BioCT
  • Facilitated Panel Discussion, Facilitated by Usha Pillai 
, Ph.D., PMP

Panelists:  

  • Carter Winstanley, Principal, Winstanley Enterprises
  • Mike Harris, Director, Elm City Innovation Collaborative
  • Dr. Todd E. Arnold, Chief Laboratory Operations Officer, Sema4
  • Pat Larrabee, President, Facility Logix
  • Miguel Ilzarbe, Director of Operations, Jackson Labs

 


This program is sponsored by

 

  • $20 per person, pre registration required. 

 

REGISTER HERE

 


Our Panelists

Carter Winstanley

Carter Winstanley, a principal of Winstanley Enterprises since 1992, has over 27 years of real estate development experience. He has developed a wide range of commercial real estate product types, with a particular expertise in the lab/biotech/technology space. Since the late 1990s, Mr. Winstanley has acquired and redeveloped over 4 million square feet of commercial real estate worth approximately $550 million. In New Haven, CT alone, Mr. Winstanley has acquired and redeveloped over 1.8 million square feet of commercial real estate including the acquisition and renovation of the 518,000 square foot former Southern New England Telephone building into one of Connecticut’s leading and most flexible biotech facilities. Mr. Winstanley also constructed a 513,000 square foot Class-A , LEED Silver, life sciences building, which in conjunction with the Yale School of Medicine and 300 George Street, solidifies New Haven as the cornerstone of the State of Connecticut’s life sciences industry.


Michael Harris

Michael Harris is the Director of the Elm City Innovation Collaborative, a network of researchers, community leaders, and entrepreneurs focused on building New Haven's life science, software, and creative economies. The recipient of CTNext's competitive "Innovation Places" award, ECIC funds 14 programs across the city that support talent development, inclusive entrepreneurship, and creative place-making. Previously an aide for New Haven's Mayor Toni Harp, Michael Harris' roles ranged from developing and implementing the City's legislative agenda to coordinating cross-department special projects on data-driven governance and participatory government. As the program coordinator for Democracy School, Michael Harris spends his volunteer time on providing accessible civics education, believing that raising public understanding of government is the key to improving our public life. A native of Los Angeles, California, Michael worked on a cattle ranch, biodynamic vineyard, and coral reef research vessel before finding a new home in New Haven, Connecticut.


Todd Arnold, Ph.D.

Dr. Todd E. Arnold is the Chief Laboratory Operations Officer for Sema4, a spinout company of the Mount Sinai Health System.  Sema4 is a patient-centered health intelligence company founded on the idea that more information, deeper analysis, and increased engagement will improve the diagnosis, treatment, and prevention of disease.  Prior to his role at Sema4, he was the Managing Director of the Mount Sinai Genetic Testing Laboratory—Connecticut and spearheaded the establishment this state of the art, high throughput nucleic acid sequencing facility. 

 Previously Dr. Arnold was the Vice President of Research and Development at 454 Life Sciences, a Roche Company, where he and his team developed next generation sequencing instruments, reagents, assays, and software.  Prior to joining 454 he was the Director of Product Development and Applications Support for Healthcare at CUNO, Incorporated, a 3M Company. He and his team introduced innovative filtration and separation media for use in therapeutic monoclonal antibody purification and pharmaceutical applications, as well as creating multiple diagnostic membrane platforms.  He earned his B.S. in Biological Sciences from Indiana University, his Ph.D. in Molecular Biology and Genetics from the University of Georgia and was a postdoctoral fellow at Harvard Medical School.  Dr. Arnold is an adjunct assistant professor at the University of Connecticut in the Department of Molecular and Cell Biology.

An active participant in curriculum development at colleges and universities, Dr. Arnold served on the advisory boards of the Connecticut Health and Life Sciences Career Initiative and the Genomic Workforce Consortium. He is currently a member of BioCT’s (the bioscience industry’s voice in the state of Connecticut) Board of Directors and Government Affairs Committee, the New Haven Region Bioscience Career and Academic Pathway (BioPath) Advisory Board, the Workforce Advisory Board of the National Professional Science Master’s Association, the Workforce Advisory Board for the Professional Science Master's Health Care Genetics Graduate Program at the University of Connecticut, and the Chairman of the Graduate Education Advisory Board at the University of Georgia. In addition, he is a member of CBIA’s Connecticut Bioscience Growth Council, the Connecticut Health Data Collaborative, and BioArray Genetics’ scientific advisory board.


 Pat Larrabee

Pat is the founder and President of Facility Logix. She has over 30 years of experience in the biotechnology industry, including several years as a bench researcher. For the past 20 years, Pat has applied her technical end-user knowledge to the facility-related needs of the industry. She advises developers and institutions across the United States and manages facility expansion and implementation programs for clients such as Eisai, George Mason University, Integrated Biotherapeutics, Johns Hopkins University, The Mayo Clinic, United Therapeutics, and the Wisconsin Alumni Research Foundation. Pat has conducted numerous feasibility studies for shared wetlab co-work, incubation, and accelerator facilities and has developed life science strategies for economic development groups across the country. Prior to founding Facility Logix, Pat was an Executive Vice President at Scheer Partners. Pat holds an MS in Biotechnology Management and a BA in Biology. In 2016, The Daily Record named Pat one of the Top 100 Women in Maryland.


 Miguel Ilzarbe

Miguel Ilzarbe joined Jackson Laboratory in September of 2018 as Director of Operations and Administration. In this role he is responsible for all operational and administrative functions.

Previously Mr. Ilzarbe was Vice President of Executive Operations at Flagship Pioneering, a scientific innovation and venture capital firm in Cambridge MA with $2.6B under management. As a Sr. Advisor to Flagship’s CEO, Mr. Ilzarbe focused on strategic development, operational leadership of VentureLabs, the firm’s innovation foundry, and support of early stage companies.

Miguel was previously the Chief of Staff and the Director of Operations and Management, within the Broad Institute of Harvard and MIT’s Directors Office. He administratively spearheaded a large international multidisciplinary effort at the Broad titled SIGMA (Slim Initiative in Genomic Medicine for the Americas). SIGMA, a $134M dollar collaboration with the Carlos Slim Health Institute aims to understand the genetic basis of Diabetes, Cancer and Kidney disease with a focus on Latin American populations.

Prior to the Chief of Staff role, Miguel served as the assistant director of the Genome Sequencing and Analysis Program at the Broad. In this capacity he was responsible for project management and administrative issues within the program. He came to the Broad from the Dana-Farber/Harvard Cancer Center, where he was responsible for all subcontracting and financial activities of the center, as well as leading a team that had fiduciary responsibility over all of Dana-Farber’s core facilities.

Before his career in research administration, Miguel spent two years as a lab supervisor of Dana-Farber’s DNA sequencing facility, four years at the sequencing facility at Memorial Sloan-Kettering Cancer Center and four years in military intelligence.

Miguel holds a bachelor’s degree in Diagnostic Genetic Sciences from the University of Connecticut and an MBA in Technology Management from the University of Phoenix. He also completed Electronic Warfare Coursework in the United States Navy.


Our Moderator

Usha Pillai, Ph.D., PMP

Dr. Usha Pillai is the Founder and President of Aria Management Consulting, LLC, specializing in strategy, critical thinking, change management, and project/program management. With over sixteen years in the pharmaceutical industry, seven years in academia, and close to a decade of consulting experience she has deep knowledge of the pharmaceutical industry and a passion for entrepreneurship and education.

Usha serves as the Biostrategist for the Economic Development Corporation of New Haven. In this capacity, Usha established Bioscience Clubhouse, a program dedicated to fostering science entrepreneurship and community building. The success of the Clubhouse led to its expansion across the state of Connecticut and now BioCT manages the program.

Prior to founding Aria Management Consulting, Usha held various positions with increasing responsibilities and complexities at Pfizer, Inc. She is also a senior consultant for Leading Women, an organization dedicated to women’s leadership development and advancement of gender parity at executive/management levels. Usha serves on the Connecticut Bioscience Growth Council, the Elm City Innovation Collaborative (ECIC) Board, the Advisory Board of the Biotechnology Academic and Career Pathway (BioPath), and the Garde Arts Center.

Usha is a certified Project Management Professional (PMP). She holds a bachelor’s degree in pharmacy from the Bombay College of Pharmacy, India; an Executive Masters in Technology Management from Rensselaer Polytechnology Institute; and a Ph. D. in Pharmaceutical Sciences from the University of Louisiana at Monroe. She also trained as a post-doctoral fellow at the University of Arizona in Tucson.


Member Login Login